Integrative Research supports cancer researchers studying evidence-based complementary therapies alongside conventional treatment to manage symptoms and side effects and improve patients’ quality of life.
The Joint ECOG-ACRIN Program supports cancer researchers expanding innovative phase II trials into community care settings, with the goal of reducing cancer’s burden and improving adults’ quality of life and survival.
The Gilead Oncology Grant funds collaborative, evidence-based projects to reduce social and economic barriers to cancer care and advance health equity for underserved populations.
Alliance Research Grant Program supports investigators and multidisciplinary teams conducting innovative colorectal cancer research, from proof-of-concept studies to curative science, to advance a cure.
The Decentralized Clinical Trial Initiative (DCTI) supports oncology trial teams conducting technology-informed treatment studies that bring investigational care closer to patients, ideally at home.